-
FDA approves updated Covid vaccines from Pfizer and Moderna as hospitalizations rise
The Biden administration said it expects the new Pfizer and Moderna vaccines targeting the omicron variant XBB.1.5 to be available in mid-September.
-
Moderna, Pfizer say updated Covid vaccines were effective against highly mutated BA.2.86 variant in trials
Moderna, Pfizer and Novavax are slated to roll out new vaccines targeting XBB.1.5 within weeks, pending approvals from the FDA.
-
Covid vaccine stocks jump as new variants emerge ahead of fall shot rollout
Novavax, Moderna, Pfizer and its partner BioNTech are slated to roll out new shots designed to target the omicron subvariant XBB.1.5 this fall.
-
New Covid vaccines from Pfizer, Moderna and Novavax will likely protect against Eris variant
The drugmakers designed their updated coronavirus shots to target the omicron subvariant XBB.1.5, which is slowly declining nationwide.
-
New Covid vaccines are coming to the U.S. this fall, but uptake may be low — Here's why
Pfizer, Moderna and Novavax are slated to deliver new single-strain Covid shots targeting the omicron subvariant XBB.1.5 in September.
-
Biden administration asks Pfizer, Moderna and Novavax for ‘reasonable' prices on updated Covid vaccines
Pfizer, Moderna and Novavax have not disclosed the exact pricing of their new vaccines, which will target the circulating omicron subvariant XBB.1.5.
-
Moderna Files for FDA Approval of Updated Covid Vaccine for Fall
Moderna said the submission is based on the FDA’s recommendation that vaccine makers update their jabs to target omicron subvariant XBB.1.5.
-
FDA recommends that updated Covid shots target omicron subvariant XBB.1.5 this fall
The FDA’s decision is a win for vaccine makers Pfizer, Moderna and Novavax, which have all been developing versions of their Covid shots to target XBB.1.5.
-
Updated Covid Boosters Cut the Infection Risk From XBB.1.5 Subvariant by Nearly Half, CDC Finds
The updated Covid boosters reduce the risk of Covid infection from the predominant omicron subvariant by nearly half, according to early data published Wednesday by the Centers for Disease Control and Prevention.
-
XBB Subvariant Now 83% of All COVID Cases in New England. But Don't Be Alarmed
The XBB omicron subvariants are now causing over 80% of COVID-19 infections in New England, according to the latest data from the Centers for Disease Control and Prevention. The XBB.1.5 variant, which accounted for only about 10% of COVID cases in the region as recently as last month, now makes up 81.7% of all cases, with another 1.3% attributed to XBB....
Your search for "xbb.1.5" returned 25 results.
